Health
Chronicle Pharmabiz
Devices sector raises concern over notification proposing fee for tests
THE medical devices industry has raised concern over the Department of Health and Family Welfares' draft notification introducing fee for test or evaluation of medical devices and mandating inclusion of licence number of sub contractor on the product labels. The Department published the draft notification on April 10, proposing various amendments to the Medical Devices Rules (MDR), 2017 including introduction of fee for test or evaluation of 11 types of tests or evaluation.
2 min |
April 30, 2026
Chronicle Pharmabiz
Panel asks DoP to take efforts to decrease imported content in medical devices
OBSERVING that a majority of the medical devices market is addressed by imports, the Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DOP) to take measures including promotion of stronger collaboration among the industry, academic institutions and research organisations to accelerate indigenous development of advanced medical devices.
1 min |
April 30, 2026
Chronicle Pharmabiz
AI in endoscopy will improve detecting early-stage cancer markers
INDIA has been moving steadily towards better cancer care. However, many cancers in India are still detected late, especially those in the digestive system.
2 min |
April 30, 2026
Chronicle Pharmabiz
Telangana appoints DG of DCA as compounding authority
IN a significant move to streamline regulatory compliance under the newly enacted Jan Vishwas provisions, the Government of Telangana has officially designated the Director General (DG) of the state’s Drugs Control Administration (DCA), Shahnawas Quasim, as the 'Compounding Authority'.
2 min |
April 30, 2026
Chronicle Pharmabiz
AIOCD seeks PM's intervention against e-pharmacies
THE All India Organisation of Chemists & Druggists (AIOCD), representing over 12.40 lakh pharmacists and distributors, has formally petitioned Prime Minister Narendra Modi to intervene against the unregulated growth of e-pharmacies and predatory pricing by large corporate entities.
1 min |
April 30, 2026
Chronicle Pharmabiz
Shed The Cavalier Attitude
A Parliamentary Panel has recently asked the Department of Pharmaceuticals (DoP) to take corrective steps to remove any administrative and procedural delays related to the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.
2 min |
April 30, 2026
Chronicle Pharmabiz
DCOIWA slams new DCGI recruitment rules, cites dilution of tech standards
THE Drugs Control Officers (I) Welfare Association (DCOIWA), the national body of drug regulatory officers in the country, has criticised the Union Heath Ministry's newly notified recruitment rules for the post of DCGI, labelling them as a serious policy lapse.
1 min |
April 30, 2026
Chronicle Pharmabiz
Experts highlight the need for data exclusivity to protect MSMES
EXPERTS have highlighted the need for clinical data exclusivity in order to protect MSME drug innovators in India.
2 min |
April 30, 2026
Chronicle Pharmabiz
Mid-sized hospitals in Tier-2 cities stranded in a financial vacuum: Expert
MID-sized hospitals in Tier-2 cities are currently trapped in a financial vacuum. This is because funding usually arrives either too early as venture capital or too late as a financial buyout, said Rakshith Rangarajan, equity fund manager, Inviga Investment Advisors.
2 min |
April 30, 2026
Chronicle Pharmabiz
Indian healthcare sector faces escalating cyber risks
INDIAN healthcare sector is confronting a surge in cyber threats as increasingly complex hospital IT ecosystems create multiple vulnerabilities for potential breaches.
2 min |
April 30, 2026
Chronicle Pharmabiz
Indian ophthalmologists power the shift toward scalable eye care
INDIAN ophthalmologists are powering a decisive shift toward scalable eye care by deploying innovative, technology-driven strategies that expand access beyond traditional hospital settings.
2 min |
April 30, 2026
Chronicle Pharmabiz
Centre to amend Rule 89 of D&C Rules for better clarity
THE Union Health Ministry has issued a draft notification to amend Rule 89 of Drugs and Cosmetics Rules, 1945 related to drug manufacturing for examination, test or analysis, to cover a wider range of allopathic drug manufacturers including those manufacturing vaccines, recombinant DNA (r-DNA) derived drugs and stem cell companies under its gamut, bringing in better clarity to the rule.
3 min |
April 30, 2026
Chronicle Pharmabiz
FOPE urges Petroleum Min to prioritise LPG supply to pharma sector
THE Federation of Pharma Entrepreneurs (FOPE) is now concerned about the shortage of LPG (Liquefied Petroleum Gas) following the looming uncertainty with the ongoing war in West Asia.
1 min |
March 19, 2026
Chronicle Pharmabiz
BDCDA informs FDA about challenges to implement geo-tagging
THE Bangalore District Chemists and Druggists Association (BDCDA) has apprised the Karnataka FDA about the practical challenges in implementing the FDA's geo-tagging application.
1 min |
March 19, 2026
Chronicle Pharmabiz
₹1,000 cr MedTech Fund signals shift toward domestic mfg
THE Indian medical technology sector is poised for a major transformation with the launch of MedArtha Capital, the nation’s first dedicated Rs.1,000 crore growth fund focused exclusively on medtech.
1 min |
March 19, 2026
Chronicle Pharmabiz
Pharma exports to GCC countries affected by US-Israel-Iran conflict: Experts
PHARMA exports to the Gulf Cooperation Council (GCC) countries like UAE, Saudi Arabia and West Asia-North Africa (WANA) region have been badly affected due to the USIsrael-Iran conflict.
2 min |
March 19, 2026
Chronicle Pharmabiz
SEPC, AHPI hold program for wellness centres & MVTF
THE Services Export Promotion Council (SEPC) India and the Association of Healthcare Providers (AHPI) India successfully held its first meeting recently on creating an accreditation programme for Wellness Centers and Medical Value Travel Facilitators (MVTF).
1 min |
March 19, 2026
Chronicle Pharmabiz
DGFT launches risk sharing support to boost exports
IN a strategic move to expand India's global export footprint, the DGFT has introduced a new intervention under the Export Promotion Mission (EPM) aimed at strengthening export financing and improving trade access to under-served markets.
1 min |
March 19, 2026
Chronicle Pharmabiz
'Need to transition from awareness reporting to performance-oriented PV'
THERE is a need to transition from awareness-driven reporting to a performance-oriented pharmacovigilance (PV) framework with measurable outcomes, said Dr V Kalaiselvan, secretary-cum-scientific director, the Indian Pharmacopoeia Commission (IPC) at the 1st Annual Meeting of Regional Centres participating in the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI).
1 min |
March 19, 2026
Chronicle Pharmabiz
India's drug quality surveillance hits new highs
THE Central Drugs Standard Control Organisation (CDSCO) has released a comprehensive report detailing the quality surveillance of pharmaceuticals across India over the last five fiscal years.
2 min |
March 19, 2026
Chronicle Pharmabiz
Pharma Quality Excellence Awards 2026 in Mumbai
In an era of heightened regulatory scrutiny, global supply chain complexity, and accelerated innovation, compliance alone is no longer sufficient.
1 min |
March 19, 2026
Chronicle Pharmabiz
Healthcare workforce eyes AI dominance via digital upskilling
INDIA'S healthcare workforce, armed with digital upskilling, is poised for AI dominance, but there are certain creases in the system that need to be ironed out for more efficient integration.
1 min |
March 19, 2026
Chronicle Pharmabiz
AstraZeneca's Imfinzi in combo receives EU nod
ASTRAZENECA'S Imfinzi (durvalumab) in combination with standard-ofà care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the European Union (EU) for the treatment of adult patients with resectable, early-stage and locally advanced (Stages II, III, IVA) gastric and gastroesophageal junction (GEJ) cancers.
1 min |
March 19, 2026
Chronicle Pharmabiz
DTAB recommends to amend Sch K to allow unflavoured nicotine sold under exemption
THE Drugs Technical Advisory Board (DTAB) has recommended amendment of Schedule K of the Drugs Rules, 1945 to restrict the over-the-counter sale of nicotine gums to unflavoured nicotine gums 2 mg, and to exclude nicotine lozenges 2 mg from the Schedule so that it should be sold under the provisions of sale license.
3 min |
March 19, 2026
Chronicle Pharmabiz
Precision medicine, reimbursement: Next frontier for payers & providers
PRECISION medicine has transformed healthcare from organ-based treatment algorithms to biologically stratified care.
4 min |
March 19, 2026
Chronicle Pharmabiz
Centre to amend Rules to mandate PAC submission to licensing authority
THE Union Health Ministry has issued a draft amendment to various rules under the D&C Rules, 1945, to include requirement of the manufacturing and loan licenses for drugs, biopharmaceuticals, and those under the Indian Systems of Medicine, among others, mandating submission of information related to post approval changes (PACs) with the licensing authority.
1 min |
March 19, 2026
Chronicle Pharmabiz
RDCA celebrates 30 years of leadership in Delhi's pharma trade
THE Retail Distribution Chemists Alliance (RDCA), the apex body for pharmaceutical traders in the National Capital Territory of Delhi, is commemorating a landmark 30-year journey of service to the industry.
1 min |
March 19, 2026
Chronicle Pharmabiz
IPC to host 37th Skill Devpt Programme on PV
THE Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre (NCC) for the Pharmacovigilance Programme of India (NCC-PvPI), is set to host the 37th Skill Development Programme (SDP) on Pharmacovigilance (PV) scheduled from 15 to 19 June, 2026 through offline or classroom mode.
1 min |
March 19, 2026
Chronicle Pharmabiz
IIT Roorkee opens Ashok Soota molecular medicine facility at BSBE
INDIAN Institute of Technology Roorkee (IIT Roorkee) inaugurated the Ashok Soota Molecular Medicine Facility at the Department of Biosciences and Bioengineering (BSBE), marking a significant step in strengthening advanced biomedical research infrastructure aligned with national healthcare priorities and global scientific advancements.
1 min |
March 19, 2026
Chronicle Pharmabiz
INTERPHEX Week Tokyo 2026 to be held from May 20 to 22 at Makuhari Messe
INTERPHEX Week Tokyo 2026, one of Japan’s largest and most influential trade shows for the pharmaceutical and biotechnology sectors, is set to return from May 20 to 22 at Makuhari Messe with an expanded showcase expected to surpass its 2025 performance and deliver a more dynamic experience for global industry professionals.
1 min |